Search

everythinglearnresearchcommunity

for

Search:↓

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Cell aging can be both good and bad for tissue repair.

Finasteride reduces hair growth and is safe for women with excessive hair.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

Menopause affects hair and skin; more research needed for treatment.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Finasteride doesn't affect bone density in male rats.

Minoxidil nanoparticles can potentially be a more effective treatment for hair growth than current treatments.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Suppressing certain hormones might help prevent prostate cancer.

People with Down's syndrome often have more skin problems due to a weak immune system.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Safflower has been used in traditional medicine for centuries and shows promise in treating heart, brain, and inflammatory conditions, but more research is needed to ensure its safety.